SPL 2.11% 9.3¢ starpharma holdings limited

Ann: DEP irinotecan combination data presentation, page-17

  1. 12,863 Posts.
    lightbulb Created with Sketch. 1411
    Clinicians and oncologists in cancer research understand the significance of Starpharma's results

    It seems for the most part investors do not

    Otherwise this stock would be worth multiple times what it currently sits at

    How much is Starpharma's Dep Irinotecan value

    How much would a big Pharma pay if it was sold outright

    How much will this single drug generate in annual royalties
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.